Viraquest Inc

ViraQuest, Inc.(now part of Antibodies Inc.) is a leading biotechnology company specializing in the rapid production of adenoviral vectors. Known for our innovative RAPAd® technology, we deliver custom adenovirus constructs with the fastest turnaround times in the industry—often in as little as three weeks. Our patented RAPAd® process combined with streamlined subcloning steps ensures high-quality constructs without the complications of revertants. At ViraQuest, we’ve always believed in partnering with our clients to advance research success. With a focus on custom adenoviral services, including novel constructs, dual-expressing vectors, and amplifications, we are committed to providing the best materials and support for adenovirus-based research. Now as part of Antibodies Inc, we continue to drive innovation, delivering cutting-edge adenoviral tools and solutions for the scientific community. Let our expertise and technology keep your research moving forward.